SCM
LSBPW

Saba Capital Management’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Saba Capital Management’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97,299
Closed -$3.55K – 361
2025
Q2 		$3.55K Hold
97,299
– – ﹤0.01% 302
2025
Q1 		$4.01K Hold
97,299
– – ﹤0.01% 245
2024
Q4 		$7.73K Hold
97,299
– – ﹤0.01% 253
2024
Q3 		$6.43K Hold
97,299
– – ﹤0.01% 300
2024
Q2 		$5.45K Hold
97,299
– – ﹤0.01% 346
2024
Q1 		$6.97K Hold
97,299
– – ﹤0.01% 348
2023
Q4 		$3.17K Hold
97,299
– – ﹤0.01% 464
2023
Q3 		$4.01K Hold
97,299
– – ﹤0.01% 534
2023
Q2 		$5.3K Hold
97,299
– – ﹤0.01% 577
2023
Q1 		$15.2K Buy
+97,299
New +$14.7K ﹤0.01% 661

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Saba Capital Management's LSBPW Position: Q3 2025 in Review

Saba Capital Management sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 97,299 shares — an estimated $3.55K sold.

Saba Capital Management first reported a position in LSBPW in Q1 2023 and held it in 10 quarters. The position peaked at $15.2K in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Saba Capital Management reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Saba Capital Management sold 97,299 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $3.55K.
  • Saba Capital Management first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 10 quarters.
  • Saba Capital Management's LakeShore Biopharma Warrants position peaked at $15.2K in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Saba Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.